BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Child Thriving After Becoming World’s Youngest to Receive Gene Therapy for AADC Deficiency

  November 18, 2024

   · 

  7 min read
• Press Releases

  Precede Biosciences Presents New Data at AACR LBx 2024 Demonstrating an Accurate Readout of Tumor PSMA Expression and Stratification of Response to Lutetium-PSMA in Men with mCRPC from a Simple Blood Test

  November 18, 2024

   · 

  2 min read
• Press Releases

  Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024

  November 18, 2024

   · 

  13 min read
• Press Releases

  Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis

  November 18, 2024

   · 

  13 min read
• Press Releases

  AbelZeta Presents Preclinical Data from Study of C-CAR168 for the Treatment of Autoimmune Diseases at ACR Convergence 2024

  November 18, 2024

   · 

  5 min read
• Press Releases

  International Cancer Organizations Present Collaborative Work During Oncology Event in China

  November 18, 2024

   · 

  3 min read
• Press Releases

  Bluejay Therapeutics Reports Best-in-Class Monoclonal Antibody BJT-778 Achieved 100% Virologic Response and Up To 78% Combined Virologic Response and ALT Normalization as Monotherapy in Participants With Chronic Hepatitis D (CHD)

  November 18, 2024

   · 

  7 min read
• Press Releases

  Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

  November 18, 2024

   · 

  4 min read
• Press Releases

  Syndax Announces FDA Approval of Revuforj® (revumenib), the First and Only Menin Inhibitor to Treat Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation

  November 18, 2024

   · 

  15 min read
• Press Releases

  Dante Genomics to Launch Generative AI Features in Dante Labs Whole Genome Platform

  November 18, 2024

   · 

  2 min read